Results 181 to 190 of about 339,768 (366)

A study on eye movement test and visuospatial optimization of wayfinding perception in large-scale comprehensive transportation hubs [PDF]

Leilei Zhai, Haishan Xia, Ran Xu, Jinyan Shao, Jianye Zhai, Jiamin Nie   +5 more
openalex   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Comparative Analysis of Dental Treatment Accuracy Using 2.5× Magnification Loupes Versus the Naked Eye: A Randomized Clinical Trial. [PDF]

Cureus
Rohit T, Prudhvi SS, Nagarakanti S, B S, Bandi H, Madhu Hasini K.   +5 more
europepmc   +1 more source

Scale effect analysis on calm water resistance using model basin testing conditions and CFD [PDF]

Shona Cunningham, Jennifer Green
openalex   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

A priori sample size determination and power analysis in metabolic phenotyping and integrative metabolomics: an application framework based on a systematic review of literature. [PDF]

Metabolomics
Bragazzi NL, Dobani S, Rinaldi de Alvarenga JF, Mignogna C, Del Rio D, Mena P.   +5 more
europepmc   +1 more source

Clinical Performance of International and Korean Genetic Testing Criteria for Hereditary Breast Cancer: A Large-Scale Cohort Analysis of 2,188 Individuals [PDF]

Bom-Yi Lee, Hyun Jeong Lee, Jiyoung Kim, Dongwon Kim, Jiwon Jeong, Kyungah Yoh, E. Kang, Sung-Won Kim   +7 more
openalex   +1 more source

Rethinking on the Test/Scale Reliability

, 2022
Yasuharu Okamoto
openalex   +2 more sources

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

A test of first order scaling in Nf=2 QCD

, 2007
We complete our analysis of Nf=2 QCD based on the lattice staggered fermion formulation. Using a series of Monte Carlo simulations at fixed (amq*Ls^yh) one is able to test the universality class with given critical exponent yh.
Pica, C., Giacomo, A. Di, Cossu, G., D'Elia, M.   +3 more
core